HealthcareRezolute rises as FDA lifts clinical hold on hyperinsulinism therapyBy Helitra.com·September 10, 2024·1 min read Rezolute rises as FDA lifts clinical hold on hyperinsulinism therapy Source: SeekingalphaADVERTISEMENT ADVERTISEMENTClinical FDA hold hyperinsulinism lifts Rezolute rises therapy Post navigation Previous storyEvaxion reports positive mid-stage trial data on lead cancer vaccine candidate EVX-01Next storyAutonomix rises after it reports reduction of pain in pancreatic cancer treatment
Fitness · HealthcareShould you sleep with socks on? Doctors weigh inNovember 5, 2026You know those people who are always cold? That’s me. So it should come as no surprise that I wear socks (and Crocs!)…
Fitness · HealthcareExercise Lowers Dementia Risk—But There’s a Surprising Catch, Study FindsNovember 5, 2026For years, experts have emphasized the importance of exercise and physical activity in reducing dementia risk—and for good reason. Research shows that people…
Fitness · HealthcareWashing Your Hair but Ignoring Your Scalp? A Dermatologist Explains Why That’s a MistakeNovember 5, 2026You might have an expensive shampoo, a nourishing conditioner and a shelf full of hair masks, but if you’re not paying attention to…